866-997-4948(US-Canada Toll Free)

Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2016

Published By :

Current Partnering

Published Date : Feb 2016

Category :

Oncology

No. of Pages : 407 Pages

The Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2016

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Personalized Medicine in Oncology dealmaking

2.1. Introduction
2.2. Personalized Medicine in Oncology partnering over the years
2.3. Most active Personalized Medicine in Oncology dealmakers
2.4. Personalized Medicine in Oncology partnering by deal type
2.5. Personalized Medicine in Oncology partnering by therapy area
2.6. Deal terms for Personalized Medicine in Oncology partnering
2.6.1 Personalized Medicine in Oncology partnering headline values
2.6.2 Personalized Medicine in Oncology deal upfront payments
2.6.3 Personalized Medicine in Oncology deal milestone payments
2.6.4 Personalized Medicine in Oncology royalty rates

Chapter 3 – Leading Personalized Medicine in Oncology deals

3.1. Introduction
3.2. Top Personalized Medicine in Oncology deals by value

Chapter 4 – Most active Personalized Medicine in Oncology dealmakers

4.1. Introduction
4.2. Most active Personalized Medicine in Oncology dealmakers
4.3. Most active Personalized Medicine in Oncology partnering company profiles

Chapter 5 – Personalized Medicine in Oncology contracts dealmaking directory

5.1. Introduction
5.2. Personalized Medicine in Oncology contracts dealmaking directory

Chapter 6 – Personalized Medicine in Oncology dealmaking by technology type

Biomarkers
Companion diagnostics
Personalised medicine
Pharmacogenomics

Chapter 7 – Partnering resource center

7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices

Appendix 1 – Personalized Medicine in Oncology deals by company A-Z

Appendix 2 – Personalized Medicine in Oncology deals by stage of development

Discovery
Preclinical
Phase I
Phase II
Phase III
Regulatory
Marketed

Appendix 3 – Personalized Medicine in Oncology deals by deal type

Asset purchase
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Co-promotion
CRADA
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Manufacturing
Marketing
Option
Promotion
Research
Spin out
Sub-license
Supply
Technology transfer

Appendix 4 – Personalized Medicine in Oncology deals by therapy area

Bladder cancer
Bone cancer
Brain cancer
Breast cancer
Cervical cancer
Colorectal cancer
Endometrial
Esophageal cancer
Gastric cancer
Head and neck cancer
Kidney cancer
Leukemia
Acute lymphoblastic leukemia
Acute myelogenous leukemia
Chronic lymphocytic leukemia
Chronic myelogenous leukemia
Liver cancer
Lung cancer
Non small cell lung cancer
Lymphoma
Non Hodgkin's lymphoma
Melanoma
Mesothelioma
Metastases
Multiple myeloma
Ovarian cancer
Pancreatic cancer
Prostate cancer
Renal cell carcinoma
Sarcoma
Solid tumors
Symptoms
Oral mucositis
Testicular cancer
Thyroid cancer

Appendix 5 –Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from Current Partnering

List of Table

NA

List of Chart

Table of figures

Figure 1: Personalized Medicine in Oncology partnering since 2010
Figure 2: Active Personalized Medicine in Oncology dealmaking activity– 2010 to 2016
Figure 3: Personalized Medicine in Oncology partnering by deal type since 2010
Figure 4: Personalized Medicine in Oncology partnering by disease type since 2010
Figure 5: Personalized Medicine in Oncology deals with a headline value
Figure 6: Personalized Medicine in Oncology deals with an upfront value
Figure 7: Personalized Medicine in Oncology deals with a milestone value
Figure 8: Personalized Medicine in Oncology deals with a royalty rate value
Figure 9: Top Personalized Medicine in Oncology deals by value since 2010
Figure 10: Most active Personalized Medicine in Oncology dealmakers 2010 to 2016
Figure 11: Online partnering resources
Figure 12: Forthcoming partnering events

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports

  • Oncology Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018

    Oncology is the study of Cancer. Oncology devices market consists of medical devices involved in diagnosing and treating the disease cancer. The Oncology devices market could be segmented into 2 major categories: by type and by applications. There are two types of Brachytherapy devices and the Endoscopic devices. The segmentation of the market as per the applications is as follows: external radiation beam therapy, Systemic radiation therapy...

  • Biologicals In Oncology Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

    Biological therapy is defined as use of living organisms and substances derived from organism or synthetically produced version of such substances in laboratories to treat the disease condition. Some of the biological therapies for cancer involve vaccines or bacteria to stimulate the body’s defense system to act against cancer cells. The biologicals in oncology market is majorly differentiated into three major segments, on the basis of biol...